From: Structured reporting to improve transparency of analyses in prognostic marker studies
ID | Study | Journal | Markers | Outcomes | Variables | Events for primary outcome | Events for all outcomes reported | Information on exclusionsa | Subgroup analysisb |
---|---|---|---|---|---|---|---|---|---|
b1 | Hayashi | BCRT | 1 | 1 | 3 | Unknown | No | 3c | Â |
b2 | Huzell | BCRT | 1 | 2 | 7 | 100 | Yes | 3 | 2 |
b3 | Jerzak | BCRT | 2 | 2 | 14 | 36 | Yes | 2 | Â |
c1 | Billingsley | Cancer | 1 | 2 | 8 | Unknown | No | 3 | Â |
c2 | Huang | Cancer | 3 | 2 | 8 | 257 | Yes | 3 | 2 |
c3 | Price | Cancer | 1 | 1 | 9 | Unknown | No | 1 | 0 |
e1 | Gonzalez-Vallinas | EJC | 1 | 1 | 9 | 22 | Yes | 2 | Â |
e2 | Hokuto | EJC | 1 | 5 | 13 | 86 | No | 1 | Â |
e3 | Thurner | EJC | 1 | 3 | 6 | 24 | Yes | 2 | 0 |
i1 | Keck | IJC | 2 | 2 | 10 | Unknown | No | 1 | 0 |
i2 | Roedel | IJC | 2 | 4 | 7 | 27 | Yes | 1 | 1 |
i3 | Schirripa | IJC | 3 | 1 | 11 | Unknown | No | 1 | 0 |
j1 | Martin | JCO | 2 | 1 | 8 | 6294 | Yes | 3 | 2 |
j2 | Ostronoff | JCO | 2 | 6 | 10 | Unknown | No | 2 | 2 |
j3 | JCO | 1 | 1 | 9 | 338 | Yes | 1 | 2 |